Event Content

The biotech industry faces rapid transformation driven by technological innovation, global market shifts, and healthcare cost pressures, creating critical demand for cost-efficient, scalable biologics manufacturing. Enzene's response is EnzeneX™ 2.0, the next evolution of their Fully-Connected Continuous M...

Continuous manufacturing: A view into the Future of Pharmaceuticals Production Pharmaceutical manufacturing is evolving. As the industry looks for ways to enhance efficiency, improve quality, and strengthen supply chains, continuous manufacturing is emerging as a powerful alternative to traditional batch p...

With an increasing industry emphasis on complex modalities, sustainable manufacturing and medicine accessibility, the spotlight has been cast on continuous biomanufacturing as a solution. Our MaruX™ technology platform provides a third dimension to our scale-up and scale-out offering that can be leveraged...

Pennsylvania is at the forefront of Biologics innovations. To fully realize its potential, the state and industry requires robust collaboration with academia. Universities and research institutions have a vital role to play, from cultivating talent and driving research to fostering technology transfer and ...

Amid growing global demands and complexities, resilience and agility have become essential for success in today’s pharmaceutical supply chains. The COVID-19 pandemic, geopolitical tensions, and reliance on foreign manufacturing have underscored vulnerabilities in the supply of APIs—the building blocks of m...

As regulations in healthcare grow more complex, U.S. pharmaceutical companies are turning to artificial intelligence to stay ahead. "Compliance By Design" highlights how integrating AI into daily processes can help pharma companies prevent compliance issues before they happen, streamline audits, and reduce...

• Alternative Approaches to Boost Patient Enrolment Amid Recruitment Challenges • How the Rising Pressures of Patient Recruitment Are Challenging Traditional Enrolment Methods

This session will begin with an introduction to Informa's Sustainability Partner, Adelphe, offering an overview of the organization and its mission. • Experts will discuss what defines recyclable packaging, the current recycling pathways, and what can be expected in the future. • Additionally, the s...

The current exemptions from PPWR and the like which are afforded to pharma packaging won't last forever. In this session we shall explore sustainable solutions that are being delivered industry wide, as well as considering specific material changes which can reduce overall carbon emissions.

In the rapidly evolving landscape of pharmaceutical manufacturing, the TT&GO® platform by Suanfarma CDMO stands out as a revolutionary solution for technology transfer. This session will explore into the unique methodology of TT&GO®, which integrates rigorous, systematic procedures grounded in risk-based a...

Join us as we explore the role sustainability professionals within organizations to shape and drive the sustainability ambition and agenda. Discover how sustainability professionals—from leaders to cross-functional teams—are shaping a culture of environmental responsibility, streamlining actions towards ne...

The drug delivery market is experiencing a significant transformation due to the need to reduce patient care costs, especially with the growing number of people dealing with chronic diseases. The aim of transitioning to self-administered medications at home, while also remotely monitoring patient complianc...

Dr Jing Li, President; Senior VP of Process Chemistry of PharmaBlock (USA) Inc., speaks in an interview from CPHI Milan 2024 on their recent win for the ACS Green Chemistry Award. PharmaBlock is invested in innovation for sustainability, PharmaBlock has a strong vision to drive the sustainable developm...

The following session has been SOLD OUT. For any inquiries, please contact a member of staff on the day Take a break from the show floor and join us for a bite, network with colleagues, and stay informed with the latest updates and insights on US Pharma regulations. Join attorneys from Womble Bond Dickin...

Reviewing the outcome of the inflation reduction act and how it is affecting pharmaceutical manufacturers and distributors in managing drug pricing within the supply chain, including:
Examining broader economic and market trends influencing drug pricing within the supply chain economy and their eff...

Pharma is guilty of gender disparity across its workforce and has historically been male dominated. Part of the problem could be that when it comes to roles in STEM, there still exists an ‘implicit bias’. How can we address the unconscious bias associated with the healthcare industry, and pave the way for ...

As the landscape, development, and introduction of large-volume delivery systems continue to grow, the implementation of these devices in the Pharma ecosystem creates unique challenges for pharmaceutical companies. From the selection of drug containment materials and enclosures, to device assembly needs to...

Learn about the different coating technologies for rubber stoppers, their unique features, and their applications in the pharmaceutical industry. Additionally, discover UltraShield™, Datwyler's latest development that meets the highest demands for drug compatibility and cold storage.

Ferrar’s objective is to lead change towards more sustainable production by adopting criteria and commitments that minimize the environmental footprint of its containers and packaging
For this, it has designed the Sustainable Packaging Model, with the participation of Anthesis Lavola.
The Mo...

Reactions involving metal catalysis, both homogeneous as well as heterogenous catalysis and chiral organic synthesis are always subjects of great interest in organic synthesis. All these reactions involve the usage of metals such as, Ni, Pd, Pt, Rh, Ru etc.. Not only the cost of these metals but also the e...

We finished off the day by learning to understand the latest trends and developments in the CDMO space, and strategies for developing successful partnerships. • Market trends and developments in the CDMO space • Reviewing your in-house capabilities to determine what services you need • Best pract...

Most pharmaceutical companies are slowly adopting an electronic method to manage the quality of operational processes and organisational priorities across the value chain. Join us and hear from our expert on how to maximise automation systems in your supply chain. • Obtain the quality information you n...

Watch this fireside chat, where Stephen Chen of Tevogen Bio will go through the opportunities and challenges in Allogeneic Cells: • Current quality and manufacturing procedures • Reviewing short- and long-term challenges • Forecasting the opportunities for Allogenic Cells

Join our focused session, where our market expert will provide an insightful analysis of the supply chain set-up from the pandemic to now. Understand the industry learnings from Covid and what has evolved within the supply chain industry: • Reviewing current developments in pharmaceutical supply chain ...

Managing the biopharma supply chain is a highly complex undertaking that is becoming ever more so as the number of new products rises and new process technologies are introduced. Moving with ease from one step to the next (R&D, production, distribution) while adhering to regulations and meeting customer de...

Join our thought leadership session to understand the current state of Psychedelics in the pharmaceutical industry. Delve into the potential psychedelics can bring and why the industry needs to take notice of its growing importance: • How psychedelics can play a role in the treatment of mental healt...

• Market needs for a device to deliver high drug loads to lungs. • Introduction to the Orbital device – features and benefits. • Comparative performance of Orbital to other DPI devices. • Different types of molecules and formulations made using different particle engineering technologies, inc...

For the past 20 years in healthcare, Polypropylene (PP) has been the most utilized plastic across a range of applications, from high-risk applications such as IV parenteral packaging to medical devices and diagnostics. PP offers alternatives to glass, metal and other plastics, such as PS or PVC. The press...

Implementing sustainability in pharmaceutical packaging needs a two-way methodology: on the one hand, a scientific, data-driven approach to support today’s industrial solutions; on the other hand, a ground-breaking , never-stopping innovation research to anticipate future evolutions. With this Learning...

Advances in auto-injector design now provide the option to use both 1ml and 2.25mL syringes plus employ technology to adapt to varying fill volumes and viscosities all whilst maintaining the same device form. This provides a solution for the formulation changes that take place during drug development, clin...

Future Predictions on Drugs from Sales & Forecast • Looking ahead to see the shape and direction of the Pharma market. • Using Sales and Forecasts to see which areas are predicted to lead or lag. • Identifying key therapy areas and indications as well as molecule types that may come to dominate t...

Indena is relentlessly working to generate a sustainable impact on its stakeholders, cultivating with care its own precious circle: Nature, Technology, and People. In terms of actual projects and actions, Indena's commitment in sustainability includes responsible supply chain management, a circular economy...

Pharmaceutical and Biotechnology companies are exposed to more than their fair share of ESG risks, that, if not addressed properly, can have significant financial and reputational impacts in the long run. To measure a company’s level of exposure with industry-specific material ESG risks and how well a comp...

For the past few years, the traditional one-size-fits-all go-to-market strategy, predominantly based on customer interactions through physical channels, has failed to support drug launches and meet business objectives. Inadequate or incomplete understanding of customer needs has been identified as one of t...

In this webinar, originally part of Pharmapack Europe 2022, Bernd Garska, Technical Marketing Manager Healthcare EMEA, Covestro AG discusses how until now, drug delivery devices would require tedious sorting with a variety of materials used in various components. Now, with an all-polycarbonate device, mini...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Stefan Lutzmayer, Consultant, IQVIA discusses how as biologics and specialty medicines increase in importance in global healthcare, especially when access to medicines and biosimilars become growth areas, this brings various oppor...

In this webinar, originally part of Pharmapack Europe 2022, Roberto Valenti, Head of Materials Development, Bormioli Pharma talks about combining sustainable packaging with pharma requirements. Strict regulatory frameworks and rigorous safety standards lead many to believe that pharma requirements and sust...

In this webinar, originally part of Pharmapack Europe 2022, Thomas Watts, Engineering Consultant, Team Consulting discusses tackling the challenges of cloud connectivity. The electronic Product Information initiative for Medicines (ePI) aim to ease the accessibility on product information to everyone with...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, speaker Nigel Langley, Director Technical Service & Scientific Affairs, BASF Pharma Solutions reviews the 'Novel Excipient Review Pilot Program'. Launched at the end of 2021, the voluntary Novel Excipient Review Pilot Program (Pilot...

Talk of bringing back domestic manufacturing to North America has dominated conversations around pharma manufacturing for years, and have been a key talking point in government post-pandemic recovery plans, but how far have we come and who is this really working for? Asian CDMO’s recognizing the trend f...

In this webinar, originally broadcast as part of CPHI North America 2022, Frances Zipp, President and CEO, Lachmann Consultants Services discusses lessons learned and best practices for these relationships that can be applied to both accelerated approvals as well as “normal” drug supply during non-pandemic...

CDMO’s accelerating adoption Reshoring: CM can help when competing with Asian producers on price. Government investment during Covid to protect against supply chain issues & increased focus on critical drugs supply New guidance based on GMP - ICH Q13 will likely see smaller companies deciding to ...